Dermatologicals is back on an upward trajectory, however nevertheless, the rate of rebound is lower than seen in many other drug categories. Despite the increasing number of diagnosed skin diseases (such as atopic dermatitis), many Polish consumers underestimate the symptoms and delay treatment. In addition, the COVID-19 pandemic influenced an increase in hygiene levels which, together with the restriction of facilities such as gymnasiums and swimming pools, reduced the prevalence of fungal dise...
Euromonitor International's Dermatologicals in Poland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market's major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Dermatologicals in Poland
Euromonitor International
September 2022
List Of Contents And Tables
DERMATOLOGICALS IN POLAND
KEY DATA FINDINGS
2022 DEVELOPMENTS
Dermatologicals back on an upward trend as lifestyles return to normal
Hair loss treatments maintains high demand
Multifunctional products rise in demand, such as those with both medicinal and aesthetic effects
PROSPECTS AND OPPORTUNITIES
Future growth will be driven by skin care trends and online shopping
Natural alternatives are gaining in popularity, boosted by celebrity and influencer endorsements
Nutricosmetics is a growing competitor to pharmaceuticals
CATEGORY DATA
Table 1 les of Dermatologicals by Category: Value 2017-2022
Table 2 les of Dermatologicals by Category: % Value Growth 2017-2022
Table 3 O Company Shares of Dermatologicals: % Value 2018-2022
Table 4 N Brand Shares of Dermatologicals: % Value 2019-2022
Table 5 recast Sales of Dermatologicals by Category: Value 2022-2027
Table 6 recast Sales of Dermatologicals by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN POLAND
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 nsumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 8 fe Expectancy at Birth 2017-2022
MARKET DATA
Table 9 les of Consumer Health by Category: Value 2017-2022
Table 10 les of Consumer Health by Category: % Value Growth 2017-2022
Table 11 O Company Shares of Consumer Health: % Value 2018-2022
Table 12 N Brand Shares of Consumer Health: % Value 2019-2022
Table 13 netration of Private Label in Consumer Health by Category: % Value 2017-2022
Table 14 stribution of Consumer Health by Format: % Value 2017-2022
Table 15 stribution of Consumer Health by Format and Category: % Value 2022
Table 16 recast Sales of Consumer Health by Category: Value 2022-2027
Table 17 recast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2021-2022
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources